These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2686415)
41. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program. Wagenlehner FM; Sobel JD; Newell P; Armstrong J; Huang X; Stone GG; Yates K; Gasink LB Clin Infect Dis; 2016 Sep; 63(6):754-762. PubMed ID: 27313268 [TBL] [Abstract][Full Text] [Related]
42. Empirical treatment in patients with acute obstructive pyelonephritis. Pasiechnikov S; Buchok O; Sheremeta R; Banyra O Infect Disord Drug Targets; 2015; 15(3):163-70. PubMed ID: 26321323 [TBL] [Abstract][Full Text] [Related]
43. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464 [TBL] [Abstract][Full Text] [Related]
44. The efficacy, safety and tolerance of ceftazidime for the treatment of bacterial infections in the elderly. Vozza A; Zerman AM; Bertoni L; Cattini GC; Tosto L; Greco N; Romano F; Panebianco R; Benedetti M J Hosp Infect; 1990 Apr; 15 Suppl A():87-9. PubMed ID: 1971652 [TBL] [Abstract][Full Text] [Related]
45. Multiple bilateral renal abscesses in a previously healthy young patient. Tang RY; Cheong BM Med J Malaysia; 2017 Aug; 72(4):250-251. PubMed ID: 28889140 [TBL] [Abstract][Full Text] [Related]
46. Sequential intravenous/oral therapy with ciprofloxacin in severe infection. Chrysanthopoulos CJ; Starakis JC; Skoutelis AT; Bassaris HP Am J Med; 1989 Nov; 87(5A):225S-227S. PubMed ID: 2589365 [No Abstract] [Full Text] [Related]
47. Treatment of serious infections with intravenous ciprofloxacin. Scully BE; Neu HC Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062 [TBL] [Abstract][Full Text] [Related]
48. [New prospects in the treatment of urinary tract infections with modified-release ciprofloxacin]. Trinchieri A Arch Ital Urol Androl; 2006 Sep; 78(3 Suppl 1):1-8. PubMed ID: 17469403 [No Abstract] [Full Text] [Related]
49. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria. Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051 [TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. Fass RJ Antimicrob Agents Chemother; 1987 Feb; 31(2):148-50. PubMed ID: 3566244 [TBL] [Abstract][Full Text] [Related]
51. Therapeutic efficacy of intravenous and oral ciprofloxacin in experimental murine infections. Nishino T; Obana Y Chemotherapy; 1996; 42(2):140-5. PubMed ID: 8697889 [TBL] [Abstract][Full Text] [Related]
52. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group. Davis C Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317 [TBL] [Abstract][Full Text] [Related]
53. Effect of oral ciprofloxacin on fecal bacteria in elderly patients. Höffler U; Grünig F; Brehmer B J Chemother; 1989 Jul; 1(4 Suppl):617-8. PubMed ID: 16312558 [No Abstract] [Full Text] [Related]
54. Criteria for use of intravenous ciprofloxacin for infections in adult patients. Frisolone J; Manzo J; Leviton IM Clin Pharm; 1993 Mar; 12(3):226-32. PubMed ID: 8491080 [No Abstract] [Full Text] [Related]
55. Clinical study of intravenous and oral ciprofloxacin in complicated bacterial infections. Gelfand MS; Simmons BP; Craft RB; Grogan JT Am J Med; 1989 Nov; 87(5A):235S-237S. PubMed ID: 2589369 [No Abstract] [Full Text] [Related]
56. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study. Pisani E; Bartoletti R; Trinchieri A; Rizzo M J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Fourcroy JL; Berner B; Chiang YK; Cramer M; Rowe L; Shore N Antimicrob Agents Chemother; 2005 Oct; 49(10):4137-43. PubMed ID: 16189090 [TBL] [Abstract][Full Text] [Related]
58. Follow-up therapy with ciprofloxacin in severe infection, an alternative to parenteral treatment. Bassaris HP; Chrysanthopoulos CJ; Skouelis AT; Starakis JC J Chemother; 1989 Jul; 1(4 Suppl):676-7. PubMed ID: 16312588 [No Abstract] [Full Text] [Related]
59. Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia. Gangji D; Jacobs F; de Jonckheer J; Coppens L; Serruys E; Hanotte F; Motte S; Thys JP Am J Med; 1989 Nov; 87(5A):206S-208S. PubMed ID: 2589362 [No Abstract] [Full Text] [Related]